Motilal Oswal Alternates has acquired a significant minority stake in Sensa Core for $72 million, aiming to enhance product development and expand its global reach in the medical diagnostic sector.

Information on the Target

Motilal Oswal Alternates has made a substantial investment by acquiring a minority stake in Sensa Core, a prominent manufacturer of medical diagnostic equipment, for $72 million. Founded in 2006 by Dr. Ravi Kumar Meruva, Sensa Core specializes in the design, development, manufacturing, and distribution of advanced in-vitro diagnostic devices. The company has established itself as a market leader in electrolyte analyzers, achieving widespread adoption across over 40,000 hospitals and diagnostic laboratories in India, while also exporting to more than 78 countries.

In addition to its strong position in electrolyte analyzers, Sensa Core is recognized as one of India's leading players in the production of glucometers and hemoglobinometers. Recently, the company has expanded its product range to include arterial blood gas analyzers, reflecting its commitment to providing innovative healthcare solutions. They operate a specialized manufacturing facility in Hyderabad’s Export Promotion Industrial Park and are set to enhance their operational capabilities with a new facility at the Medical Device Park in Sultanpur.

Industry Overview in India

The medical device industry in India is rapidly growing, fueled by increasing healthcare needs and rising investments in healthcare infrastructure. Despite being a significant market, India relies heavily on imports for medical devices,